When Alzheimer's degrades cells that cross hemispheres, visual memory suffers

by Massachusetts Institute of TechnologyScientists traced and studied neurons that connect the visual cortices in each hemisphere of the brain. Credit: Chinnakkaruppan Adaikkan/MIT PIcower Instit

Updated on: May 20,2024

When Alzheimer's degrades cells that cross hemispheres, visual memory suffers

by Massachusetts Institute of TechnologyScientists traced and studied neurons that connect the visual cortices in each hemisphere of the brain. Credit: Chinnakkaruppan Adaikkan/MIT PIcower Instit

Updated on:May 20,2024

Big data reveals new Alzheimer's risk genes

by University of EdinburghPET scan of a human brain with Alzheimer's disease. Credit: public domainAn international research team led by scientists at the University of Edinburgh and the Univ

Updated on: May 20,2024

Big data reveals new Alzheimer's risk genes

by University of EdinburghPET scan of a human brain with Alzheimer's disease. Credit: public domainAn international research team led by scientists at the University of Edinburgh and the Univ

Updated on:May 20,2024

How common nutritional supplements may protect against traumatic brain injuries in sports

by Max Esterhuizen,Virginia TechCredit: Pixabay/CC0 Public DomainThe pouring rain and blustery wind gusts are brutal. The crowd is bone-chillingly cold, but they don't care.Their favorite fo

Updated on: February 05,2024

How common nutritional supplements may protect against traumatic brain injuries in sports

by Max Esterhuizen,Virginia TechCredit: Pixabay/CC0 Public DomainThe pouring rain and blustery wind gusts are brutal. The crowd is bone-chillingly cold, but they don't care.Their favorite fo

Updated on:February 05,2024

A new biomarker makes it easier to distinguish between Alzheimer's and primary tauopathy

byLudwig Maximilian University of MunichDiscriminatory power of tau binding and p-tau between pairs of groups. Credit:Alzheimer's & Dementia(2024). DOI:10.1002/alz.14185. htt

Updated on: September 23,2024

A new biomarker makes it easier to distinguish between Alzheimer's and primary tauopathy

byLudwig Maximilian University of MunichDiscriminatory power of tau binding and p-tau between pairs of groups. Credit:Alzheimer's & Dementia(2024). DOI:10.1002/alz.14185. htt

Updated on:September 23,2024

Stool transplant shows promise for Parkinson's disease

by VIB (the Flanders Institute for Biotechnology)Credit: Pixabay/CC0 Public DomainParkinson's disease (PD) is a common neurodegenerative disease that affects millions worldwide. Now, a ground

Updated on: April 06,2024

Stool transplant shows promise for Parkinson's disease

by VIB (the Flanders Institute for Biotechnology)Credit: Pixabay/CC0 Public DomainParkinson's disease (PD) is a common neurodegenerative disease that affects millions worldwide. Now, a ground

Updated on:April 06,2024

Simple molecular reagents to treat Alzheimer's disease

by The Korea Advanced Institute of Science and Technology (KAIST)Overview of a rational strategy for designing compact aromatic molecules with multiple reactivities against pathological factors f

Updated on: June 20,2024

Simple molecular reagents to treat Alzheimer's disease

by The Korea Advanced Institute of Science and Technology (KAIST)Overview of a rational strategy for designing compact aromatic molecules with multiple reactivities against pathological factors f

Updated on:June 20,2024

Preliminary study: Drug may be safe in those with mild cognitive impairment, mild dementia

by American Academy of NeurologyCredit: CC0 Public DomainA small, preliminary study of an investigational new drug being studied for mild cognitive impairment and mild dementia associated with Al

Updated on: February 05,2024

Preliminary study: Drug may be safe in those with mild cognitive impairment, mild dementia

by American Academy of NeurologyCredit: CC0 Public DomainA small, preliminary study of an investigational new drug being studied for mild cognitive impairment and mild dementia associated with Al

Updated on:February 05,2024

Asymmetrical neuron loss in Alzheimer's

by Ludwig Maximilian University of MunichCredit: Christian Wachinger/LMUAs Alzheimer's disease progresses, neuron loss leads to marked lateral asymmetries in brain structure. A new LMU study

Updated on: March 09,2024

Asymmetrical neuron loss in Alzheimer's

by Ludwig Maximilian University of MunichCredit: Christian Wachinger/LMUAs Alzheimer's disease progresses, neuron loss leads to marked lateral asymmetries in brain structure. A new LMU study

Updated on:March 09,2024

The way the brain processes speech could serve as a predictor of early dementia

by Baycrest Centre for Geriatric CareCredit: CC0 Public DomainEarly dementia is typically associated with memory and thinking problems; but older adults should also be vigilant about hearing and

Updated on: May 13,2024

The way the brain processes speech could serve as a predictor of early dementia

by Baycrest Centre for Geriatric CareCredit: CC0 Public DomainEarly dementia is typically associated with memory and thinking problems; but older adults should also be vigilant about hearing and

Updated on:May 13,2024

Bodybuilding supplement may help stave off progression of Alzheimer's

by Rush University Medical CenterGraphical abstract. Credit:Cell Reports(2023). DOI: 10.1016/j.celrep.2023.112717RUSH researchers recently discovered that a muscle-building supplement

Updated on: June 24,2024

Bodybuilding supplement may help stave off progression of Alzheimer's

by Rush University Medical CenterGraphical abstract. Credit:Cell Reports(2023). DOI: 10.1016/j.celrep.2023.112717RUSH researchers recently discovered that a muscle-building supplement

Updated on:June 24,2024

Alzheimer's drug trial targets toxic proteases from gum disease bacteria in the brain

by Alzheimer's Research UKP. gingivalis colonies grown on blood agar. CC0 Public DomainThe pharmaceutical company, Cortexyme, Inc. has outlined a trial of potential Alzheimer's drug that

Updated on: April 16,2024

Alzheimer's drug trial targets toxic proteases from gum disease bacteria in the brain

by Alzheimer's Research UKP. gingivalis colonies grown on blood agar. CC0 Public DomainThe pharmaceutical company, Cortexyme, Inc. has outlined a trial of potential Alzheimer's drug that

Updated on:April 16,2024

IL-33 ameliorates Alzheimer's-like pathology and cognitive decline

by Hong Kong University of Science and TechnologyIL-33 in Alzheimer's disease. Credit: Division of Life Science, HKUSTAlzheimer's disease (AD) is a devastating condition with no known effectiv

Updated on: March 30,2024

IL-33 ameliorates Alzheimer's-like pathology and cognitive decline

by Hong Kong University of Science and TechnologyIL-33 in Alzheimer's disease. Credit: Division of Life Science, HKUSTAlzheimer's disease (AD) is a devastating condition with no known effectiv

Updated on:March 30,2024